- How the new Alzheimer’s drug works—and why the FDA is under fire for approving it National Geographic
- Jim Cramer on FDA resignations connected to the approval of Biogen's Alzheimer's drug CNBC Television
- The Drug That Could Break American Health Care The Atlantic
- The debate over the FDA-approved Alzheimer’s drug showcases our system’s skewed priorities The Washington Post
- The Alzheimer’s economy: is the new $56,000-a-year drug worth it? Financial Times
- View Full Coverage on Google News
from Top stories - Google News https://ift.tt/3gwYfHO
No comments
Post a Comment